omniture
SPECIALISED THERAPEUTICS AUSTRALIA PTY LTD

Latest News

Specialised Therapeutics signs exclusive license agreement with CanariaBio for new ovarian cancer therapy

.. First ovarian cancer therapy for ST oncology portfolio .. Phase 2 study demonstrated oregovomab ...

2023-10-13 03:00 2133

World Orphan Drug Alliance Welcomes Specialised Therapeutics

* SEA's largest independent specialty pharma company Specialised Therapeutics (ST) has joined glo...

2023-09-08 04:00 1710

Specialised Therapeutics acquires commercialisation rights to new oral MND therapy

.. ST to partner with Dutch biotech company Treeway BV .. First CNS therapy in ST therapeutic portf...

2023-08-28 04:00 1607

GLOBAL SARCOMA THERAPY NOW LISTED ON PHARMACEUTICAL BENEFITS SCHEME

* YONDELIS® (trabectedin) now PBS listed for Australian patients * Listing described as "wonderf...

2023-07-31 15:00 1658

LYMPHOMA THERAPY NOW APPROVED FOR AUSTRALIAN PATIENTS With Diffuse Large B-cell Lymphoma

MINJUVI® (tafasitamab) provisionally approved by Therapeutic Goods Administration[1] Recent five-y...

2023-06-28 04:00 1874

NEW THERAPY FOR RARE GASTROINTESTINAL STROMAL TUMOURS APPROVED IN SINGAPORE

* Singapore's Health Sciences Authority (HSA) has approved QINLOCK® (ripretinib) for the treatmen...

2023-05-08 04:00 1994

Specialised Therapeutics signs partnership agreement with Akeso Inc. and CTTQ-Akeso to commercialise new anti-PD1 antibody in Australia and Southeast Asia

SINGAPORE, April 11, 2023 /PRNewswire/ -- Independent biopharmaceutical company Specialised Therape...

2023-04-12 06:00 2209

GLOBAL SARCOMA THERAPY NOW APPROVED FOR NEW ZEALAND PATIENTS

* Globally regarded soft-tissue sarcoma therapy has been approved by Medsafe forNew Zealand patie...

2023-02-17 03:00 2323

NEW THERAPY TO TREAT RARE GASTROINTESTINAL STROMAL TUMOUR APPROVED FOR NEW ZEALAND PATIENTS

* QINLOCK® (ripretinib) now Medsafe approved for GIST patients in NZ * QINLOCK now being conside...

2023-01-20 02:00 2464

New treatment for rare cancer cholangiocarcinoma approved in Australia

* Available to treat adults with locally advanced or metastatic cholangiocarcinoma with an FGFR2 ...

2022-09-15 21:00 1497

NEW EARLY BREAST CANCER DRUG TO REDUCE RISK OF RECURRENCE OR DEATH NOW AVAILABLE IN THE PHILIPPINES

* NERLYNX® (neratinib) is approved by the Food and Drug Administration of the Philippines * Le...

2022-07-08 09:28 1955

New Therapy to Treat Advanced Small Cell Lung Cancer ZEPZELCA® (lurbinectedin) Approved in Singapore

Highlights: * ZEPZELCA® (lurbinectedin) is the first new therapy approved in Singapore to treat ...

2021-09-22 14:30 1714

New Therapy to Treat Advanced Small Cell Lung Cancer Approved for Australian Patients

Highlights: * ZEPZELCA® (lurbinectedin) is the first new therapy approved to treat second-li...

2021-09-14 18:57 1519

New Drug for Gastrointestinal Stromal Tumours (GIST) to be Launched in Australia, New Zealand and South East Asia Following Distribution Agreement

Key Highlights: * Specialised Therapeutics Asia (STA) to make QINLOCK® (ripretinib) available to...

2020-11-06 05:30 3710

New Early Breast Cancer Drug Now Approved in Malaysia

SINGAPORE, July 16, 2020 /PRNewswire/ -- A NEW breast cancer drug shown to significantly reduce the...

2020-07-17 06:16 2280

New Small Cell Lung Cancer Drug Accepted for TGA Evaluation Under Project Orbis

Key Highlights * TGA has granted provisional designation for new drug Lurbinectedin based on enc...

2020-06-03 14:30 1453

New Early Breast Cancer Drug Available Now In Singapore

* NERLYNX® (neratinib) now commercially available in Singapore for HER2+ breast cancer patients f...

2020-04-23 12:33 2151

Specialised Therapeutics Signs Exclusive Deal for New Haematology Drug

SINGAPORE, Dec. 18, 2019 /PRNewswire/ -- Independent pharmaceutical company Specialised Therapeutic...

2019-12-18 22:00 2778

New Early Breast Cancer Drug Approved by Singapore Health Sciences Authority

* NERLYNX® (neratinib) now approved in Singapore for HER2+ breast cancer patients following adjuv...

2019-12-03 05:30 1198